The enhanced neuroinflammatory response may mediate the pathogenesis of depression by triggering a variety of downstream pathogenesis processes, such as impairment of the monoamine system and cyclic adenosine monophosphate (cAMP)-response element binding protein (CREB)-BDNF signaling. This evidence concerns the gene BDNF and depressive symptom measurement.